HQL — Tekla Life Sciences Investors stock price, charts and financials

QT74Tekla Life Sciences Investors

Tekla Life Sciences Investors (NYSE: HQL) is a Financial Services company in the Asset Management industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
19.70
+0.43+2.23%
HQLQT74Tekla Life Sciences Investors·NYSE
19.70+2.23%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 20, 20264Statement of changes in beneficial ownership
Jun 11, 20263Initial statement of beneficial ownership
Jun 08, 2026N-CSRSCertified shareholder semi-annual report
May 29, 2026NPORT-PMonthly portfolio investments report
Apr 07, 2026DEF 14ADefinitive proxy statement
Mar 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 27, 2026NPORT-PMonthly portfolio investments report
Feb 23, 2026SC 13D/ABeneficial ownership statement (active, amended)
Feb 11, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jan 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
Dec 19, 20253Initial statement of beneficial ownership
Dec 18, 20254Statement of changes in beneficial ownership
Dec 08, 2025N-CENAnnual report on Form N-CEN
Dec 08, 2025N-CSRCertified shareholder report
Nov 26, 2025NPORT-PMonthly portfolio investments report
Nov 24, 2025SC 13D/ABeneficial ownership statement (active, amended)
Sep 26, 2025SC 13D/ABeneficial ownership statement (active, amended)
Sep 23, 20254Statement of changes in beneficial ownership
Sep 19, 20254Statement of changes in beneficial ownership
Sep 17, 20254Statement of changes in beneficial ownership
Sep 15, 20254Statement of changes in beneficial ownership
Sep 04, 20254Statement of changes in beneficial ownership
Sep 03, 2025SC 13D/ABeneficial ownership statement (active, amended)
Sep 02, 20254Statement of changes in beneficial ownership
Aug 29, 2025N-PXAnnual report of proxy voting record